// App-Quantinova.ai

3040 : Cytokine release syndrome (CRS) in patients treated with NY-ESO-1c259 TCR.

Researchers

Presenter

  • Crystal Mackall

Principal Investigators

  • Sandra P. D'Angelo

  • Mihaela C. Cristea

  • Kunle Odunsi

  • Elliot Norry

  • Lini Pandite

  • Tom Holdich

  • Gabor Kari

  • Indu R. Ramachandran

  • Lilliam Ribeiro

  • Gwendolyn Binder-Scholl

  • Rafael G. Amado

Medical Centers

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA

  • Roswell Park Cancer Institute, Buffalo, NY

  • Adaptimmune, Philadelphia, PA

  • Adaptimmune, Abingdon, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Cytokine release syndrome

Biomarkers

  • C reactive protein

  • Cytokine

  • Twist-related protein 1

  • T-cell receptor

Drug/Treatment

  • NY-ESO-1c259

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved